AGEN
Price
$7.50
Change
-$0.41 (-5.18%)
Updated
Jul 31 closing price
Capitalization
312.32M
8 days until earnings call
Intraday BUY SELL Signals
TAOX
Price
$3.29
Change
-$0.09 (-2.66%)
Updated
Jul 31 closing price
Capitalization
24.58M
Intraday BUY SELL Signals
Interact to see
Advertisement

AGEN vs TAOX

AGEN vs TAOX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AGEN vs. TAOX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGEN is a Hold and TAOX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 03, 2026
Stock price -- (AGEN: $7.50 vs. TAOX: $3.29)
Brand notoriety: AGEN and TAOX are both not notable
AGEN represents the Biotechnology, while TAOX is part of the Investment Banks/Brokers industry
Current volume relative to the 65-day Moving Average: AGEN: 36% vs. TAOX: 69%
Market capitalization -- AGEN: $312.32M vs. TAOX: $24.58M
AGEN [@Biotechnology] is valued at $312.32M. TAOX’s [@Investment Banks/Brokers] market capitalization is $24.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.09B to $0. The market cap for tickers in the [@Investment Banks/Brokers] industry ranges from $928.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B. The average market capitalization across the [@Investment Banks/Brokers] industry is $13.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGEN’s FA Score shows that 1 FA rating(s) are green whileTAOX’s FA Score has 1 green FA rating(s).

  • AGEN’s FA Score: 1 green, 4 red.
  • TAOX’s FA Score: 1 green, 4 red.
According to our system of comparison, AGEN is a better buy in the long-term than TAOX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGEN’s TA Score shows that 6 TA indicator(s) are bullish while TAOX’s TA Score has 4 bullish TA indicator(s).

  • AGEN’s TA Score: 6 bullish, 5 bearish.
  • TAOX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, AGEN is a better buy in the short-term than TAOX.

Price Growth

AGEN (@Biotechnology) experienced а +25.42% price change this week, while TAOX (@Investment Banks/Brokers) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.22%. For the same industry, the average monthly price growth was -8.12%, and the average quarterly price growth was +2790.29%.

The average weekly price growth across all stocks in the @Investment Banks/Brokers industry was +0.01%. For the same industry, the average monthly price growth was -6.73%, and the average quarterly price growth was -16.94%.

Reported Earning Dates

AGEN is expected to report earnings on Aug 11, 2026.

Industries' Descriptions

@Biotechnology (-1.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Investment Banks/Brokers (+0.01% weekly)

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AGEN($312M) has a higher market cap than TAOX($24.6M). AGEN YTD gains are higher at: 138.853 vs. TAOX (-10.598). AGEN has higher annual earnings (EBITDA): 127M vs. TAOX (-9.29M). AGEN has more cash in the bank: 35M vs. TAOX (3.65M). AGEN has higher revenues than TAOX: AGEN (124M) vs TAOX (688K).
AGENTAOXAGEN / TAOX
Capitalization312M24.6M1,268%
EBITDA127M-9.29M-1,367%
Gain YTD138.853-10.598-1,310%
P/E Ratio3.66N/A-
Revenue124M688K18,023%
Total Cash35M3.65M960%
Total Debt41.1MN/A-
FUNDAMENTALS RATINGS
AGEN: Fundamental Ratings
AGEN
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AGENTAOX
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
Bearish Trend 18 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
Aroon
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AGEN
Daily Signal:
Gain/Loss:
TAOX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PAWAX74.630.66
+0.89%
T. Rowe Price All-Cap Opportunities-Adv
TIOVX17.690.04
+0.23%
Nuveen International Opps W
HILVX20.71-0.01
-0.05%
Harbor Large Cap Value Inv
HRLYX11.03-0.04
-0.36%
Hartford Real Asset Y
JABGX14.23-0.08
-0.56%
JHancock Real Estate Securities I

TAOX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TAOX has been closely correlated with NCNA. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if TAOX jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TAOX
1D Price
Change %
TAOX100%
-2.66%
NCNA - TAOX
92%
Closely correlated
+4.76%
RNAC - TAOX
91%
Closely correlated
+0.91%
AGEN - TAOX
91%
Closely correlated
-5.18%
ALLR - TAOX
87%
Closely correlated
-1.63%
NRXP - TAOX
84%
Closely correlated
+0.96%
More